Norges Bank
SNDX icon

Norges Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Norges Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-169,100
Closed -$4.3M – 2158
2022
Q4 		$4.3M Sell
169,100
-19,100
-10% -$445K ﹤0.01% 1818
2022
Q3 		$4.52M Buy
+188,200
New +$4.22M ﹤0.01% 1788
2022
Q2 		– Sell
-484,900
Closed -$8.43M – 2159
2022
Q1 		$8.43M Hold
484,900
– – ﹤0.01% 1756
2021
Q4 		$10.6M Buy
+484,900
New +$8.96M ﹤0.01% 1740
2016
Q3 		– Sell
-24,768
Closed -$244K – 2170
2016
Q2 		$244K Sell
24,768
-232
-0.9% -$3.18K ﹤0.01% 2149
2016
Q1 		$333K Buy
+25,000
New +$314K ﹤0.01% 2150

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return